The growing number of pipeline studies for memantine use is likely to drive the memantine industry forward. For example, in September 2016, Lille University Hospital began a phase I clinical research to examine the effects of memantine on cognitive behaviour in Alzheimer's disease patients. The investigation is expected to be finished by February 2019. The growing number of medication patents that have expired is a key impediment to the worldwide memantine market's growth. Because of the rising number of generic versions of memantine on the market, North America is likely to keep a dominating position in the global memantine market. Furthermore, due to major companies' increased focus on producing memantine tablets, Asia Pacific is likely to exhibit considerable development in the Global Memantine Market.
Prominent Companies in the Memantine Industry:
1. Lupin Limited
Lupin Limited, a pharmaceutical company, develops, produces, markets, and sells a range of branded and generic formulations, biotechnology products, and active pharmaceutical ingredients (APIs). It operates in India, the United States, the United Kingdom, South Africa, Australia, the Philippines, Germany, the Netherlands, Mexico, and Brazil. Lupin Limited was founded in 1968 and is headquartered in Mumbai, India.
2. Allergan plc
The company is Operator of a pharmaceutical company intended to focus on manufacturing and commercializing branded pharmaceutical, device, biologic, surgical and regenerative medicine products. The company engages in medical aesthetics, eye care, central nervous system and gastroenterology and delivers innovative patient care. Founded in 1983, headquartered in Dublin.
3. Novartis AG
Novartis AG researches, develops, manufactures, and markets healthcare products in Switzerland and internationally. The company operates through two segments: Innovative Medicines and Sandoz. Novartis AG has a license and collaboration agreement with Alnylam Pharmaceuticals to develop, manufacture, and commercialize inclisiran, a therapy to reduce LDL cholesterol. Novartis AG was incorporated in 1996 and is headquartered in Basel, Switzerland.